INCIDENCE OF A SUBCLINICAL FASCIOLIASIS ON ANTIPYRINE CLEARANCE AND METABOLITE EXCRETION IN SHEEP

被引：38
|
作者：
TUFENKJI, AE [1 ]
ALVINERIE, M [1 ]
PINEAU, T [1 ]
BOULARD, C [1 ]
GALTIER, P [1 ]
机构：
[1] INRA,PHARMACOL TOXICOL LAB,180 CHEM DE TOURNEFEUILLE,F-31300 TOULOUSE,FRANCE
来源：
XENOBIOTICA | 1988年 / 18卷 / 04期
关键词：
D O I：
10.3109/00498258809041671
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：357 / 364
页数：8
相关论文
共 36 条
  • [1] ANTIPYRINE CLEARANCE AND METABOLITE EXCRETION IN PATIENTS WITH CHRONIC HEPATITIS-C
    ALI, HA
    ELYAZIGI, A
    SIECK, JO
    ALI, MA
    RAINES, DA
    SAOUR, J
    ERNST, P
    KHAN, B
    DOSSING, M
    [J]. JOURNAL OF HEPATOLOGY, 1995, 22 (01) : 17 - 21
  • [2] DISPOSITION OF PREDNISOLONE IN THE COURSE OF SUBCLINICAL FASCIOLIASIS IN SHEEP
    ALVINERIE, M
    SUTRA, JF
    GALTIER, P
    TOUTAIN, PL
    [J]. XENOBIOTICA, 1993, 23 (05) : 483 - 493
  • [3] The effect of experimental fascioliasis on the pharmacokinetics of antipyrine and sulphadimidine in desert sheep
    Elsheikh, HA
    Ali, BH
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1997, 20 (03) : 167 - 172
  • [4] Antipyrine clearance and metabolite excretion in Saudi patients with non-alcoholic chronic liver disease
    Ali, HA
    ElYazigi, A
    Sieck, JO
    Ali, MA
    Dossing, M
    Raines, DA
    Saour, J
    Ernst, P
    Khan, B
    [J]. ANNALS OF SAUDI MEDICINE, 1995, 15 (05) : 473 - 477
  • [5] THE EFFECTS OF SUBCLINICAL FASCIOLIASIS ON HEPATIC SECRETORY FUNCTION IN SHEEP
    FERRE, I
    LOPEZ, P
    GONZALOORDEN, M
    JULIAN, MD
    ROJOVAZQUEZ, FA
    GONZALEZGALLEGO, J
    [J]. PARASITOLOGY RESEARCH, 1995, 81 (02): : 127 - 131
  • [6] PHARMACOKINETICS OF AMPICILLIN AND PENTOBARBITAL IN THE COURSE OF SUBCLINICAL FASCIOLIASIS IN SHEEP
    TUFENKJI, AE
    ALVINERIE, M
    LARRIEU, G
    HOUIN, G
    GALTIER, P
    [J]. RESEARCH IN VETERINARY SCIENCE, 1991, 50 (01) : 75 - 80
  • [7] Antipyrine Clearance and Metabolite Formation in Primary Biliary Cirrhosis
    F. Jorquera
    M. Almar
    A. Linares
    J. L. Olcóz
    L. Rodrigo
    J. González-Gallego
    [J]. Digestive Diseases and Sciences, 2001, 46 : 352 - 359
  • [8] ANTIPYRINE CLEARANCE AND METABOLITE FORMATION IN PATIENTS WITH ALCOHOLIC CIRRHOSIS
    TEUNISSEN, MWE
    SPOELSTRA, P
    KOCH, CW
    WEEDA, B
    VANDUYN, W
    JANSSENS, AR
    BREIMER, DD
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (05) : 707 - 715
  • [9] FACTORS AND CONDITIONS AFFECTING ANTIPYRINE CLEARANCE AND METABOLITE FORMATION
    TEUNISSEN, MWE
    [J]. PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1986, 8 (02) : 151 - 152
  • [10] Antipyrine clearance and metabolite formation in primary biliary cirrhosis
    Jorquera, F
    Almar, M
    Linares, A
    Olcóz, JL
    Rodrigo, L
    González-Gallego, J
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2001, 46 (02) : 352 - 359
1234